Company Performance Metrics
- Stephan Michels: Co- Founder
- Miguel Serrano Kieckebusch: Chief Executive OfficerPast Role: Medtronic, Vice President of Global Pricing Strategy & Revenue Management
Ophthorobotics was founded in November 2014 and is headquartered in Switzerland. Their team of world class engineers and ophthalmic specialists is passionate about providing a high-tech solution for the delivery of intravitreal injections to treat many chronic ocular diseases.
Ophthorobotics is a Swiss company committed to the development of
medical robotics. They aim to provide safe and comfortable treatment to patients, while allowing for economic efficiency through cutting-edge technology.
Ophthorobotics is developing the first fully automated system capable of performing safe and precise injections into the eye for the efficient treatment of several chronic ophthalmic diseases.
By providing an assistive injection system with an integrated local sterile environment and consumables to hospitals, they can increase safety for patients, increase availability of the procedure, decrease procedure times, allow for integrated data storage and documentation, and reduce costs for medical staff and expensive operating rooms.